 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$28.27 |
$28.64 |
$27.33 |
$28.22 |
1.08M | | 04/22/2024 |
$28.59 |
$28.89 |
$27.92 |
$28.74 |
874.40K | | 04/23/2024 |
$28.94 |
$29.86 |
$28.54 |
$28.61 |
1.06M | | 04/24/2024 |
$28.72 |
$29.54 |
$28.40 |
$28.80 |
731.10K | | 04/25/2024 |
$28.21 |
$28.52 |
$27.44 |
$27.75 |
1.27M |
|
|
| Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases. Co.'s product pipeline includes batoclimab and IMVT-1402, both of which are fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor. Co. is developing batoclimab, its first prodcut candidate, and IMVT-1402, its second product candidate, in autoimmune diseases for which there is evidence that pathogenic IgG antibodies drive disease manifestation. Co. is developing batoclimab for myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy and Graves' disease. | |
|
Immunovant (IMVT) has the following price history information. Looking back at IMVT historical stock prices for the last five trading days, on April 19, 2024, IMVT opened at $28.27, traded as high as $28.64 and as low as $27.33, and closed at $28.22. Trading volume was a total of 1.08M shares. On April 22, 2024, IMVT opened at $28.59, traded as high as $28.89 and as low as $27.92, and closed at $28.74. Trading volume was a total of 874.40K shares. On April 23, 2024, IMVT opened at $28.94, traded as high as $29.86 and as low as $28.54, and closed at $28.61. Trading volume was a total of 1.06M shares. On April 24, 2024, IMVT opened at $28.72, traded as high as $29.54 and as low as $28.40, and closed at $28.80. Trading volume was a total of 731.10K shares. On April 25, 2024, IMVT opened at $28.21, traded as high as $28.52 and as low as $27.44, and closed at $27.75. Trading volume was a total of 1.27M shares.
IMVT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Immunovant shares, starting with a $10,000 purchase of IMVT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/24/2019 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$9.95 |
|
| End price/share: |
$27.75 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
178.89% |
|
| Average Annual Total Return: |
23.60% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$27,891.40 |
|
| Years: |
4.84 |
|
|
|
| Date |
Close |
| 04/19/2024 | $28.22 | | 04/22/2024 | $28.74 | | 04/23/2024 | $28.61 | | 04/24/2024 | $28.80 | | 04/25/2024 | $27.75 |
|
|
Free IMVT Email Alerts:
